Daniel Calkins

This profile gathers the share dealings of Daniel Calkins in Verastem, Inc. In total, 35 filings cover trades dated from 27 December 2022 to 1 October 2026.

Sales make up the whole of the open-market record (29 sales, €74k). The amount is not disclosed for 2 filings. Outside the open market, there are 6 share grants. In 2026 alone, the filings show no purchases and 5 sales.

The record was last updated on 2 October 2026 with a share grant in Verastem, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.